Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
b decrease » _ decrease (Expand Search), b1 decreased (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
b decrease » _ decrease (Expand Search), b1 decreased (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1641
-
1642
BL-CFCs develop from EBs with antagonized miR-24.
Published 2015“…<b>C)</b> RNA was isolated from d3, d4, and d5 EBs derived from the indicated ESC clones. …”
-
1643
Expression of miR-24 target Trib3 impairs hematopoietic development of ESCs.
Published 2015“…<p><b>A)</b> Trib3 gene expression in d4 EBs derived from the indicated ESC clones. …”
-
1644
-
1645
-
1646
-
1647
-
1648
-
1649
-
1650
-
1651
-
1652
The differences of BOLD signal timecourses (TR = 1.6 seconds) upon perceptual switches in V3A/B, V4v, and hMT+.
Published 2013“…<p>(a) The BOLD signal modulates weakly in V3A/B or V4v. …”
-
1653
-
1654
-
1655
Bortezomib in combination with the PLK1 inhibitor BI 2536 induces a significant downregulation of the total levels and phosphorylation of Bcr-Abl, a decrease of downstream phosphorylated STAT5 and a caspase-dependent cell death in TKIs-resistant and –sensitive K562 cell lines.
Published 2013“…<p><b>A</b>. K562 leukemic cells were plated in 75cm<sup>2</sup> flasks (2 x 10<sup>6</sup> cells/30 ml/flask) and treated with 9nM bortezomib, 8nM BI 2536 or the combination, for 60h. …”
-
1656
-
1657
-
1658
-
1659
-
1660